全文获取类型
收费全文 | 1778篇 |
免费 | 300篇 |
国内免费 | 40篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 104篇 |
妇产科学 | 19篇 |
基础医学 | 93篇 |
口腔科学 | 26篇 |
临床医学 | 315篇 |
内科学 | 588篇 |
皮肤病学 | 60篇 |
神经病学 | 171篇 |
特种医学 | 279篇 |
外科学 | 189篇 |
综合类 | 31篇 |
预防医学 | 56篇 |
眼科学 | 16篇 |
药学 | 102篇 |
中国医学 | 1篇 |
肿瘤学 | 55篇 |
出版年
2024年 | 9篇 |
2023年 | 52篇 |
2022年 | 13篇 |
2021年 | 29篇 |
2020年 | 90篇 |
2019年 | 13篇 |
2018年 | 88篇 |
2017年 | 69篇 |
2016年 | 69篇 |
2015年 | 60篇 |
2014年 | 98篇 |
2013年 | 110篇 |
2012年 | 48篇 |
2011年 | 38篇 |
2010年 | 76篇 |
2009年 | 110篇 |
2008年 | 44篇 |
2007年 | 55篇 |
2006年 | 44篇 |
2005年 | 28篇 |
2004年 | 16篇 |
2003年 | 13篇 |
2002年 | 19篇 |
2001年 | 33篇 |
2000年 | 16篇 |
1999年 | 28篇 |
1998年 | 82篇 |
1997年 | 97篇 |
1996年 | 80篇 |
1995年 | 69篇 |
1994年 | 49篇 |
1993年 | 55篇 |
1992年 | 34篇 |
1991年 | 20篇 |
1990年 | 27篇 |
1989年 | 57篇 |
1988年 | 43篇 |
1987年 | 34篇 |
1986年 | 21篇 |
1985年 | 24篇 |
1984年 | 18篇 |
1983年 | 10篇 |
1982年 | 14篇 |
1981年 | 14篇 |
1980年 | 14篇 |
1979年 | 8篇 |
1978年 | 8篇 |
1977年 | 9篇 |
1976年 | 10篇 |
1971年 | 8篇 |
排序方式: 共有2118条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
D B White C A Walawander D Y Liu T H Grasela 《Journal of pharmacokinetics and biopharmaceutics》1992,20(3):295-313
In a simulation study of inference on population pharmacokinetic parameters, two methods of performing tests of hypotheses comparing two populations using NONMEM were evaluated. These two methods are the test based upon 95% confidence intervals and the likelihood ratio test. Data were simulated according to a monoexponential model and, in that context, power curves for each test were generated for (i) the ratio of mean clearance and (ii) the ratio of the population standard deviations of clearance. To generate the power curves, a range of these parameters was employed; other pharmacokinetic parameters were selected to reflect the variability typically present in a Phase II clinical trial. For tests comparing the means, the confidence interval tests had approximately the same power as the likelihood ratio tests and were consistently more faithful to the nominal level of significance. For comparison of the standard deviations, and when the volume of information available was relatively small, however, the likelihood ratio test was more able to detect differences between the two groups. These results were then compared to results on parameter estimation in order to gain insight into the question of power. As an example, the nonnormality of estimates of the ratio of standard deviations plays an important role in explaining the low power for the confidence interval tests. We conclude that, except for the situation of modeling standard deviations with only sparse information, NONMEM produces tests of significance that are effective at detecting clinically significant differences between two populations. 相似文献
7.
8.
9.
筛检对肝癌死亡率影响的研究 总被引:5,自引:0,他引:5
5581名HBsAg阳性的男性随机分入周期性筛检组(A组,3712人)及对照组(B组,1869人)。A组(19155.4人年)共发生肝癌257例,B组(9785.5人年)为117例,两组的肝癌发生率分别为1342/10万与1196/10万;两组肝癌死亡分别为218与109例,肝癌死亡率分别为1138/10万与1114/10万。两组中Ⅰ期肝癌病例分别为29.6%与6.0%,差异有非常显著性意义。1、3、5年相对生存率A组为23.7%、7.0%、4.0%,B组为9.7%、4.0%、4.1%。用Poisson回归模型拟合显示,在调正年龄、初筛AFP及入列年份后,筛检对于肝癌的相对危险度为0.83,95%CI为0.68~1.03,有较弱的“保护”作用,Cox回归模型拟合结果显示当临床分期未引入模型时,筛检对于肝癌有显著的“保护”作用:危险率为0.6617,95%CI为0.5234~0.8365;而模型经调整后,危险率即接近“1”,95%CI为0.74~1.26。 相似文献
10.
Ralls PW; Johnson MB; Kanel G; Dobalian DM; Colletti PM; Boswell WD Jr; Radin DR; Halls JM 《Radiology》1986,161(2):451-454
FM sonography - a signal-processing technique that uses frequency and phase information as well as amplitude data - shows promise in evaluation of patients with diffuse liver disease. In a prospective blinded review of 37 patients with biopsy-proved liver disease and 42 healthy volunteers, FM sonography was clearly superior to traditional amplitude-based (AM) sonography in distinguishing healthy from diseased subjects. Statistically significant differences were seen in accuracy (FM, 98.7%; AM, 84.8%), sensitivity (FM, 97.3%; AM, 70.3%), and negative predictive value (FM, 97.7%; AM, 78.8%). Our data also suggest that current FM sonographic techniques cannot differentiate among histologic findings associated with different hepatic parenchymal abnormalities. It is unclear, therefore, whether FM imaging can reduce the numbers of patients who require biopsy for diagnosis or the frequency of biopsy procedures in patients with known disease. 相似文献